A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.
BMC Cancer
; 18(1): 646, 2018 Jun 08.
Article
in En
| MEDLINE
| ID: mdl-29884132
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Yttrium Radioisotopes
/
Radioimmunotherapy
/
Sarcoma, Synovial
/
Frizzled Receptors
/
Antineoplastic Agents, Immunological
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2018
Document type:
Article
Affiliation country:
France
Country of publication:
United kingdom